L-Captopril
Categoria
L-Captopril Nombres de marca, L-Captopril Analogos
L-Captopril Marca los nombres de mezcla
L-Captopril Formula quimica
L-Captopril RX enlace
L-Captopril FDA hoja
L-Captopril MSDS (hoja de seguridad de materiales)
L-Captopril Sintesis de referencia
L-Captopril Peso molecular
L-Captopril Punto de fusion
L-Captopril H2O Solubilidad
L-Captopril Estado
L-Captopril LogP
L-Captopril Formas de dosificacion
L-Captopril Indicacion
L-Captopril Farmacologia
L-Captopril Absorcion
L-Captopril Toxicidad
L-Captopril Informacion de Pacientes
Patients should be advised to immediately report to their physician any signs or symptoms suggesting angioedema (e.g., swelling of face, eyes, lips, tongue, larynx and extremities; difficulty in swallowing or breathing; hoarseness) and to discontinue therapy.
Patients should be told to report promptly any indication of infection (e.g., sore throat, fever),which may be a sign of neutropenia, or of progressive edema which might be related to proteinuria and nephrotic syndrome.
All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in blood pressure because of reduction in fluid volume. Other causes of volume depletion such as vomiting or diarrhea may also lead to a fall in blood pressure; patients should be advised to consult with the physician.
Patients should be advised not to use potassium-sparing diuret-ics, potassium supplements or potassium-containing salt substitutes without consulting their physician.
Patients should be warned against interruption or discontinuation of medication unless instructed by the physician.
Heart failure patients on captopril therapy should be cautioned against rapid increases in physical activity.
Patients should be informed that captopril should be taken one hour before meals.
